Fenbendazol Suspension

868 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

868

Total Reports

334

Deaths Reported

3850.0%

Death Rate

Active Ingredients

Fenbendazol Suspension

Administration Routes

OralUnknownTopicalSubcutaneousOtherIntravenousSubconjunctival

Species Affected

Dog 338

Cattle 312

Unknown 108

Cat 49

Goat 28

Human 11

Sheep 6

Snake 4

Pig 3

Alpaca 2

Most Affected Breeds

Cattle (other) 176

Unknown 130

Crossbred Canine/dog 58

Crossbred Bovine/Cattle 47

Aberdeen Angus 43

Domestic Shorthair 31

Dog (unknown) 23

Shepherd Dog - German 22

Beagle 20

Retriever - Golden 17

Most Reported Reactions

Death 284

Lack of efficacy - NOS 125

Diarrhoea 68

Lethargy (see also Central nervous system depression in 'Neurological') 59

Lack of efficacy (endoparasite) - hookworm 50

Containers, Leaking 44

Death by euthanasia 43

Drug administration error 41

Vomiting 40

Lack of efficacy (bacteria) - NOS 34

Emesis (multiple) 33

Seizure NOS 30

Outcome Breakdown

Ongoing

322 (30.6%)

Died

303 (28.7%)

Recovered/Normal

243 (23.1%)

Outcome Unknown

137 (13.0%)

Euthanized

44 (4.2%)

Recovered with Sequela

5 (0.5%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.